Hubing Shi
Sichuan University(CN)West China Medical Center of Sichuan University(CN)West China Hospital of Sichuan University(CN)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Synthesis and biological activity, Cancer Immunotherapy and Biomarkers, Computational Drug Discovery Methods, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation(2010)2,149 cited
- → RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)(2011)1,432 cited
- → Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy(2013)983 cited
- → Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance(2012)619 cited
- → Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance(2015)607 cited
- → Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours(2019)533 cited